© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health
PERSPECTIVE
Asthma
The use of inhaled corticosteroids during childhood: plus ça change...
Correspondence to:
Correspondence to:
Dr G Russell
Royal Aberdeen Childrens Hospital, Cornhill Road, Aberdeen AB25 2ZD, UK; libra@ifb.co.uk
Commentary on the paper by Masoli et al (see page 902)
| The first 150 words of the full text of this article appear below. |
Inhaled corticosteroid therapy (ICT) has a long and for the most part honourable history in the management of asthma. Introduced in an attempt to minimise the side effects associated with systemic treatment, early trials with nebulised hydrocortisone showed little if any added benefit,1 but with the introduction of beclomethasone dipropionate,2 ICT rapidly assumed a central rôle in the management of asthma, transforming the lives of millions of sufferers.
Early studies were reassuring, but it soon became apparent that ICT did have measurable systemic effects on the hypothalamo-pituitary-adrenal axis,3 although there was little evidence that these translated into clinically significant problems, overt corticosteroid toxicity being a rare and apparently idiosyncratic reaction.4 Worries about the very real effects of ICT on growth5 have been largely banished by the demonstration of normal adult height at follow up.6 Posterior subcapsular cataract formation has been reported in children on ICT, but mainly in children
Relevant Articles
- Atoms
- Howard Bauchner
Arch. Dis. Child. 2004 89: 893.[Extract] [Full Text] [PDF]
- Systematic review of the dose-response relation of inhaled fluticasone propionate
- M Masoli, M Weatherall, S Holt, and R Beasley
Arch. Dis. Child. 2004 89: 902-907.[Abstract] [Full Text] [PDF]
This article has been cited by other articles:
-
Townshend, J, Hails, S, Mckean, M
(2007). Management of asthma in children. BMJ
335: 253-257
[Full Text] -
Paton, J, Jardine, E, McNeill, E, Beaton, S, Galloway, P, Young, D, Donaldson, M
(2006). Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch. Dis. Child.
91: 808-813
[Abstract] [Full Text] -
Balfour-Lynn, I. M., Lees, B., Hall, P., Phillips, G., Khan, M., Flather, M., Elborn, J. S., on behalf of the CF WISE (Withdrawal of Inhaled St,
(2006). Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
173: 1356-1362
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



